Drugs and Therapy Perspectives : Impact Factor & More
eISSN: 1179-1977pISSN: 1172-0360
Share this on:
Key Metrics
CiteScore 
0.9
SJR
Q4Pharmacology (medical)
SNIP
0.19
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Drugs and Therapy Perspectives
Drugs and Therapy Perspectives Journal Specifications
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1993 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Drugs and Therapy Perspectives ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Drugs and Therapy Perspectives
Givinostat in Duchenne muscular dystrophy: a profile of its use
- 21 Apr 2026
- Drugs & Therapy Perspectives
Sarecycline in moderate to severe acne vulgaris: a profile of its use
- 12 Apr 2026
- Drugs & Therapy Perspectives
Be mindful of additional risks when using guideline-directed medical therapy to treat heart failure with preserved ejection fraction in older adults
- 26 Feb 2026
- Drugs & Therapy Perspectives
Look out for new treatment choices in chronic spontaneous urticaria
- 23 Feb 2026
- Drugs & Therapy Perspectives
Enhancing healthcare economics: the impact of manual dose rounding on T-DM1 costs in breast cancer treatment
- 22 Feb 2026
- Drugs & Therapy Perspectives
Consider brexpiprazole for agitation in Alzheimer’s disease, with new therapies under investigation for agitation and psychosis
- 13 Feb 2026
- Drugs & Therapy Perspectives
Givinostat in Duchenne muscular dystrophy: a profile of its use
- 21 Apr 2026
- Drugs & Therapy Perspectives
Sarecycline in moderate to severe acne vulgaris: a profile of its use
- 12 Apr 2026
- Drugs & Therapy Perspectives
Be mindful of additional risks when using guideline-directed medical therapy to treat heart failure with preserved ejection fraction in older adults
- 26 Feb 2026
- Drugs & Therapy Perspectives
Look out for new treatment choices in chronic spontaneous urticaria
- 23 Feb 2026
- Drugs & Therapy Perspectives
Enhancing healthcare economics: the impact of manual dose rounding on T-DM1 costs in breast cancer treatment
- 22 Feb 2026
- Drugs & Therapy Perspectives
Consider brexpiprazole for agitation in Alzheimer’s disease, with new therapies under investigation for agitation and psychosis
- 13 Feb 2026
- Drugs & Therapy Perspectives
FAQs on Drugs and Therapy Perspectives
How long has Drugs and Therapy Perspectives been actively publishing? 
What is the publishing frequency of Drugs and Therapy Perspectives?
How many articles did Drugs and Therapy Perspectives publish last year?
What is the eISSN & pISSN for Drugs and Therapy Perspectives?
What is Citescore for Drugs and Therapy Perspectives?
What is SNIP score for Drugs and Therapy Perspectives?
What is the SJR for Drugs and Therapy Perspectives?
Who is the publisher of Drugs and Therapy Perspectives?
